Deals this week: GeoVax Labs, Yisheng Biopharma, Oryzon Genomics

GeoVax Labs and ViaMune have signed a co-development agreement for cancer immunotherapy programmes.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news